Table 2 Respondents’ support of clinical trial data sharing, stratified by trialist and trial characteristics
From: Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey
|  | ‘The clinical research community should promote and facilitate clinical trial data sharing’ | |||
|---|---|---|---|---|
| Â | Respondents | Agree (%) | Disagree (%) | P value |
Overall | 317 | 278 (88) | 39 (12) | Â |
Trialist academic productivity (number of research articles published in past three years) | Â | Â | Â | 0.22 |
     1 to 10 articles | 71 | 66 (93) | 5 (7) |  |
     11 to 25 articles | 117 | 103 (88) | 14 (12) | |
     >25 articles | 129 | 109 (85) | 20 (16) | |
Trialist geographic location | Â | Â | Â | 0.17* |
     United States or Canada | 167 | 141 (84) | 26 (16) |  |
     Western Europe | 113 | 104 (92) | 9 (8) | |
     Other | 37 | 33 (89) | 4 (11) | |
Trial funding source | Â | Â | Â | 0.07* |
     Government | 120 | 108 (90) | 12 (10) |  |
     Industry or mixed funding | 152 | 127 (84) | 25 (16) | |
     Other | 45 | 43 (96) | 2 (4) | |
Trial size | Â | Â | Â | 0.71 |
     ≤239 subjects | 80 | 69 (86) | 11 (14) |  |
     240 to 2,016 subjects | 158 | 141 (89) | 17 (11) | |
     ≥2,017 subjects | 79 | 68 (86) | 11 (14) | |
Journal in which the trial was published | Â | Â | Â | 0.01* |
     NEJM | 113 | 92 (81) | 21 (19) |  |
     Lancet | 70 | 61 (87) | 9 (13) | |
     JAMA | 43 | 36 (84) | 7 (16) | |
     Annals of Internal Medicine | 24 | 23 (96) | 1 (4) | |
     The BMJ | 53 | 52 (98) | 1 (2) | |
     PLoS Medicine | 14 | 14 (100) | 0 (0) | |